These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27667150)

  • 21. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
    Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
    J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of in-stent restenosis in peripheral arteries: are DEBs sufficient as stand-alone treatment for femoro-popliteal in-stent restenosis?
    Franzone A; Stabile E; Carbone A; Scudiero F; Trimarco B; Esposito G
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):335-8. PubMed ID: 24755701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neointimal hyperplasia after silverhawk atherectomy versus percutaneous transluminal angioplasty (PTA) in femoropopliteal stent reobstructions: a controlled, randomized pilot trial.
    Brodmann M; Rief P; Froehlich H; Dorr A; Gary T; Eller P; Hafner F; Deutschmann H; Seinost G; Pilger E
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):69-74. PubMed ID: 23007223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role for DCBs in the treatment of ISR.
    Bague N; Nasr B; Chaillou P; Costargent A; Gouailler-Vulcain F; Goueffic Y
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Femoropopliteal in-stent restenosis: current treatment strategies.
    Singh GD; Armstrong EJ; Laird JR
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):325-33. PubMed ID: 24755700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of mechanical atherectomy and drug-eluting balloons for femoropopliteal in-stent restenosis.
    Beschorner U; Zeller T
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):347-9. PubMed ID: 24755703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification and clinical impact of restenosis after femoropopliteal stenting.
    Tosaka A; Soga Y; Iida O; Ishihara T; Hirano K; Suzuki K; Yokoi H; Nanto S; Nobuyoshi M
    J Am Coll Cardiol; 2012 Jan; 59(1):16-23. PubMed ID: 22192663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem).
    Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA
    Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New stents for SFA.
    MINAR E; SCHILLINGER M
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):635-45. PubMed ID: 19741579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
    Acin F; de Haro J; Bleda S; Varela C; Esparza L
    J Endovasc Ther; 2012 Oct; 19(5):585-95. PubMed ID: 23046322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V; Stabile E; Biamino G; Salemme L; Cioppa A; Giugliano G; Tesorio T; Cota L; Popusoi G; Pucciarelli A; Esposito G; Trimarco B; Rubino P
    JACC Cardiovasc Interv; 2014 Apr; 7(4):411-5. PubMed ID: 24630884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.
    Laird JR; Yeo KK; Rocha-Singh K; Das T; Joye J; Dippel E; Reddy B; Botti C; Jaff MR
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):852-9. PubMed ID: 22422738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.